Global and Japan Repurposed Drugs Market Size, Status and Forecast 2024-2031

Report ID: 1015034 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Repurposed Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Generic Drugs
        1.2.3 Clinical Trial Failed Drugs
    1.3 Market by Application
        1.3.1 Global Repurposed Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Cardiovascular Diseases
        1.3.3 Mental Illness
        1.3.4 Cancer
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Repurposed Drugs Market Perspective (2016-2027)
    2.2 Repurposed Drugs Growth Trends by Regions
        2.2.1 Repurposed Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Repurposed Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Repurposed Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Repurposed Drugs Industry Dynamic
        2.3.1 Repurposed Drugs Market Trends
        2.3.2 Repurposed Drugs Market Drivers
        2.3.3 Repurposed Drugs Market Challenges
        2.3.4 Repurposed Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Repurposed Drugs Players by Revenue
        3.1.1 Global Top Repurposed Drugs Players by Revenue (2016-2021)
        3.1.2 Global Repurposed Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Repurposed Drugs Revenue
    3.4 Global Repurposed Drugs Market Concentration Ratio
        3.4.1 Global Repurposed Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Repurposed Drugs Revenue in 2020
    3.5 Repurposed Drugs Key Players Head office and Area Served
    3.6 Key Players Repurposed Drugs Product Solution and Service
    3.7 Date of Enter into Repurposed Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Repurposed Drugs Breakdown Data by Type
    4.1 Global Repurposed Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Repurposed Drugs Forecasted Market Size by Type (2022-2027)

5 Repurposed Drugs Breakdown Data by Application
    5.1 Global Repurposed Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Repurposed Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Repurposed Drugs Market Size (2016-2027)
    6.2 North America Repurposed Drugs Market Size by Type
        6.2.1 North America Repurposed Drugs Market Size by Type (2016-2021)
        6.2.2 North America Repurposed Drugs Market Size by Type (2022-2027)
        6.2.3 North America Repurposed Drugs Market Size by Type (2016-2027)
    6.3 North America Repurposed Drugs Market Size by Application
        6.3.1 North America Repurposed Drugs Market Size by Application (2016-2021)
        6.3.2 North America Repurposed Drugs Market Size by Application (2022-2027)
        6.3.3 North America Repurposed Drugs Market Size by Application (2016-2027)
    6.4 North America Repurposed Drugs Market Size by Country
        6.4.1 North America Repurposed Drugs Market Size by Country (2016-2021)
        6.4.2 North America Repurposed Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Repurposed Drugs Market Size (2016-2027)
    7.2 Europe Repurposed Drugs Market Size by Type
        7.2.1 Europe Repurposed Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Repurposed Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Repurposed Drugs Market Size by Type (2016-2027)
    7.3 Europe Repurposed Drugs Market Size by Application
        7.3.1 Europe Repurposed Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Repurposed Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Repurposed Drugs Market Size by Application (2016-2027)
    7.4 Europe Repurposed Drugs Market Size by Country
        7.4.1 Europe Repurposed Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Repurposed Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Repurposed Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Repurposed Drugs Market Size by Type
        8.2.1 Asia-Pacific Repurposed Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Repurposed Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Repurposed Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Repurposed Drugs Market Size by Application
        8.3.1 Asia-Pacific Repurposed Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Repurposed Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Repurposed Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Repurposed Drugs Market Size by Region
        8.4.1 Asia-Pacific Repurposed Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Repurposed Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Repurposed Drugs Market Size (2016-2027)
    9.2 Latin America Repurposed Drugs Market Size by Type
        9.2.1 Latin America Repurposed Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Repurposed Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Repurposed Drugs Market Size by Type (2016-2027)
    9.3 Latin America Repurposed Drugs Market Size by Application
        9.3.1 Latin America Repurposed Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Repurposed Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Repurposed Drugs Market Size by Application (2016-2027)
    9.4 Latin America Repurposed Drugs Market Size by Country
        9.4.1 Latin America Repurposed Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Repurposed Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Repurposed Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Repurposed Drugs Market Size by Type
        10.2.1 Middle East & Africa Repurposed Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Repurposed Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Repurposed Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Repurposed Drugs Market Size by Application
        10.3.1 Middle East & Africa Repurposed Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Repurposed Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Repurposed Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Repurposed Drugs Market Size by Country
        10.4.1 Middle East & Africa Repurposed Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Repurposed Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Teva
        11.1.1 Teva Company Details
        11.1.2 Teva Business Overview
        11.1.3 Teva Repurposed Drugs Introduction
        11.1.4 Teva Revenue in Repurposed Drugs Business (2016-2021)
        11.1.5 Teva Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Repurposed Drugs Introduction
        11.2.4 Novartis Revenue in Repurposed Drugs Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Mylan
        11.3.1 Mylan Company Details
        11.3.2 Mylan Business Overview
        11.3.3 Mylan Repurposed Drugs Introduction
        11.3.4 Mylan Revenue in Repurposed Drugs Business (2016-2021)
        11.3.5 Mylan Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Repurposed Drugs Introduction
        11.4.4 Johnson & Johnson Revenue in Repurposed Drugs Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Repurposed Drugs Introduction
        11.5.4 Pfizer Revenue in Repurposed Drugs Business (2016-2021)
        11.5.5 Pfizer Recent Development
    11.6 Bausch Health
        11.6.1 Bausch Health Company Details
        11.6.2 Bausch Health Business Overview
        11.6.3 Bausch Health Repurposed Drugs Introduction
        11.6.4 Bausch Health Revenue in Repurposed Drugs Business (2016-2021)
        11.6.5 Bausch Health Recent Development
    11.7 GSK
        11.7.1 GSK Company Details
        11.7.2 GSK Business Overview
        11.7.3 GSK Repurposed Drugs Introduction
        11.7.4 GSK Revenue in Repurposed Drugs Business (2016-2021)
        11.7.5 GSK Recent Development
    11.8 ChemRar Group
        11.8.1 ChemRar Group Company Details
        11.8.2 ChemRar Group Business Overview
        11.8.3 ChemRar Group Repurposed Drugs Introduction
        11.8.4 ChemRar Group Revenue in Repurposed Drugs Business (2016-2021)
        11.8.5 ChemRar Group Recent Development
    11.9 Glenmark
        11.9.1 Glenmark Company Details
        11.9.2 Glenmark Business Overview
        11.9.3 Glenmark Repurposed Drugs Introduction
        11.9.4 Glenmark Revenue in Repurposed Drugs Business (2016-2021)
        11.9.5 Glenmark Recent Development
    11.10 Fujifilm
        11.10.1 Fujifilm Company Details
        11.10.2 Fujifilm Business Overview
        11.10.3 Fujifilm Repurposed Drugs Introduction
        11.10.4 Fujifilm Revenue in Repurposed Drugs Business (2016-2021)
        11.10.5 Fujifilm Recent Development
    11.11 Dr. Reddy
        11.11.1 Dr. Reddy Company Details
        11.11.2 Dr. Reddy Business Overview
        11.11.3 Dr. Reddy Repurposed Drugs Introduction
        11.11.4 Dr. Reddy Revenue in Repurposed Drugs Business (2016-2021)
        11.11.5 Dr. Reddy Recent Development
    11.12 R-Pharma
        11.12.1 R-Pharma Company Details
        11.12.2 R-Pharma Business Overview
        11.12.3 R-Pharma Repurposed Drugs Introduction
        11.12.4 R-Pharma Revenue in Repurposed Drugs Business (2016-2021)
        11.12.5 R-Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Repurposed Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Generic Drugs
    Table 3. Key Players of Clinical Trial Failed Drugs
    Table 4. Global Repurposed Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Repurposed Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Repurposed Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Repurposed Drugs Market Share by Regions (2016-2021)
    Table 8. Global Repurposed Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Repurposed Drugs Market Share by Regions (2022-2027)
    Table 10. Repurposed Drugs Market Trends
    Table 11. Repurposed Drugs Market Drivers
    Table 12. Repurposed Drugs Market Challenges
    Table 13. Repurposed Drugs Market Restraints
    Table 14. Global Repurposed Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Repurposed Drugs Market Share by Players (2016-2021)
    Table 16. Global Top Repurposed Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Repurposed Drugs as of 2020)
    Table 17. Ranking of Global Top Repurposed Drugs Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Repurposed Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Repurposed Drugs Product Solution and Service
    Table 21. Date of Enter into Repurposed Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Repurposed Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Repurposed Drugs Revenue Market Share by Type (2016-2021)
    Table 25. Global Repurposed Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Repurposed Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Repurposed Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Repurposed Drugs Revenue Market Share by Application (2016-2021)
    Table 29. Global Repurposed Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Repurposed Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Repurposed Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Repurposed Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Repurposed Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Repurposed Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Repurposed Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Repurposed Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Repurposed Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Repurposed Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Repurposed Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Repurposed Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Repurposed Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Repurposed Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Repurposed Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Repurposed Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Repurposed Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Repurposed Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Repurposed Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Repurposed Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Repurposed Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Repurposed Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Repurposed Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Repurposed Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Repurposed Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Repurposed Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Repurposed Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Repurposed Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Repurposed Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Repurposed Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Repurposed Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Repurposed Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Teva Company Details
    Table 62. Teva Business Overview
    Table 63. Teva Repurposed Drugs Product
    Table 64. Teva Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 65. Teva Recent Development
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Repurposed Drugs Product
    Table 69. Novartis Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Mylan Company Details
    Table 72. Mylan Business Overview
    Table 73. Mylan Repurposed Drugs Product
    Table 74. Mylan Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 75. Mylan Recent Development
    Table 76. Johnson & Johnson Company Details
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Repurposed Drugs Product
    Table 79. Johnson & Johnson Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 80. Johnson & Johnson Recent Development
    Table 81. Pfizer Company Details
    Table 82. Pfizer Business Overview
    Table 83. Pfizer Repurposed Drugs Product
    Table 84. Pfizer Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 85. Pfizer Recent Development
    Table 86. Bausch Health Company Details
    Table 87. Bausch Health Business Overview
    Table 88. Bausch Health Repurposed Drugs Product
    Table 89. Bausch Health Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 90. Bausch Health Recent Development
    Table 91. GSK Company Details
    Table 92. GSK Business Overview
    Table 93. GSK Repurposed Drugs Product
    Table 94. GSK Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 95. GSK Recent Development
    Table 96. ChemRar Group Company Details
    Table 97. ChemRar Group Business Overview
    Table 98. ChemRar Group Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 99. ChemRar Group Recent Development
    Table 100. Glenmark Company Details
    Table 101. Glenmark Business Overview
    Table 102. Glenmark Repurposed Drugs Product
    Table 103. Glenmark Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 104. Glenmark Recent Development
    Table 105. Fujifilm Company Details
    Table 106. Fujifilm Business Overview
    Table 107. Fujifilm Repurposed Drugs Product
    Table 108. Fujifilm Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 109. Fujifilm Recent Development
    Table 110. Dr. Reddy Company Details
    Table 111. Dr. Reddy Business Overview
    Table 112. Dr. Reddy Repurposed Drugs Product
    Table 113. Dr. Reddy Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 114. Dr. Reddy Recent Development
    Table 115. R-Pharma Company Details
    Table 116. R-Pharma Business Overview
    Table 117. R-Pharma Repurposed Drugs Product
    Table 118. R-Pharma Revenue in Repurposed Drugs Business (2016-2021) & (US$ Million)
    Table 119. R-Pharma Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Repurposed Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Generic Drugs Features
    Figure 3. Clinical Trial Failed Drugs Features
    Figure 4. Global Repurposed Drugs Market Share by Application: 2020 VS 2027
    Figure 5. Cardiovascular Diseases Case Studies
    Figure 6. Mental Illness Case Studies
    Figure 7. Cancer Case Studies
    Figure 8. Other Case Studies
    Figure 9. Repurposed Drugs Report Years Considered
    Figure 10. Global Repurposed Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Repurposed Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Repurposed Drugs Market Share by Regions: 2020 VS 2027
    Figure 13. Global Repurposed Drugs Market Share by Regions (2022-2027)
    Figure 14. Global Repurposed Drugs Market Share by Players in 2020
    Figure 15. Global Top Repurposed Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Repurposed Drugs as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Repurposed Drugs Revenue in 2020
    Figure 17. Global Repurposed Drugs Revenue Market Share by Type (2016-2021)
    Figure 18. Global Repurposed Drugs Revenue Market Share by Type (2022-2027)
    Figure 19. North America Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Repurposed Drugs Market Share by Type (2016-2027)
    Figure 21. North America Repurposed Drugs Market Share by Application (2016-2027)
    Figure 22. North America Repurposed Drugs Market Share by Country (2016-2027)
    Figure 23. United States Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Repurposed Drugs Market Share by Type (2016-2027)
    Figure 27. Europe Repurposed Drugs Market Share by Application (2016-2027)
    Figure 28. Europe Repurposed Drugs Market Share by Country (2016-2027)
    Figure 29. Germany Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Repurposed Drugs Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Repurposed Drugs Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Repurposed Drugs Market Share by Region (2016-2027)
    Figure 39. China Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Repurposed Drugs Market Share by Type (2016-2027)
    Figure 47. Latin America Repurposed Drugs Market Share by Application (2016-2027)
    Figure 48. Latin America Repurposed Drugs Market Share by Country (2016-2027)
    Figure 49. Mexico Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Repurposed Drugs Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Repurposed Drugs Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Repurposed Drugs Market Share by Country (2016-2027)
    Figure 55. Turkey Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Repurposed Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Teva Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 59. Novartis Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 60. Mylan Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 61. Johnson & Johnson Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 62. Pfizer Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 63. Bausch Health Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 64. GSK Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 65. ChemRar Group Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 66. Glenmark Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 67. Fujifilm Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 68. Dr. Reddy Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 69. R-Pharma Revenue Growth Rate in Repurposed Drugs Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Frequently Asked Questions
Repurposed Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Repurposed Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Repurposed Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Goserelin Drug

Goserelin Drug market is segmented by region (country), players, by Type, and by Application. Pla ... Read More